Jan 15, 2020 / 07:00PM GMT
Michael Roman Minchak - JP Morgan Chase & Co, Research Division - Analyst
Good morning, everyone, and welcome. We're very pleased to have Henry Schein presenting today at the conference. My name is Michael Minchak, and I'm a member of the health care services equity research team here.
For those of you who may not know, Henry Schein is one of the leading distributors in the dental and the medical products area as well as with technology and value-added services. So today, with us, we have CEO, Stanley Bergman; and CFO, Steve Paladino, to tell us more about the story. We're going to do a little bit of a different format here today with a fireside chat. And following the session, we'll have breakout questions in -- across the hall in the Georgian Room.
But before we begin with that, I'm going to hand it over to Stanley to make some introductory comments, and then we'll get into the Q&A.
Stanley M. Bergman - Henry Schein, Inc. - Executive Chairman & CEO
Thank you, Mike. Thank you all for being here. I'll be very brief because I'd
Henry Schein Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot